📰 Genscript Probio News
Page 3 - Genscript Probio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genscript Probio. Real-time updates on events, politics, business and more.
November 24, 2022
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global GMP Plasmid DNA Manufacturing Market By...
November 24, 2022
JERSEY CITY, N.J., Nov. 24, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global GMP Plasmid DNA Manufacturing Market By
July 14, 2022
/PRNewswire/ -- On the July 14, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and DAAN Bio Therapeutics (Byoung Chul Cho, Co-Founder & CEO),...
July 14, 2022
GenScript ProBio has entered two strategic partnership MOUs with DAAN Bio Therapeutics and ACT Therapeutics.
July 13, 2022
/PRNewswire/ -- On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing...
July 6, 2022
/PRNewswire/ -- The "IVD Raw Materials Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.coms offering. With the rise...
July 6, 2022
/PRNewswire/ -- The "IVD Raw Materials Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.coms offering. With the rise...
June 15, 2022
LEIDEN, Netherlands, June 15, 2022 /PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing
June 15, 2022
LEIDEN, the Netherlands, June 15, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of its premium 2G UNic™ technology for boosting therapeutic protein production to GenScript ProBio, a global contract...
June 15, 2022
/PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of...